ArticleMedComm2025

A Phosphatidylinositol 3-Kinase Gamma Inhibitor Enhances Anti-Programmed Death-1/Programmed Death Ligand-1 Antitumor Effects by Remodeling the Tumor Immune Microenvironment of Ovarian Cancer.

Caixia Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.